Table 2.
Characteristics of patients involved in the CD177 analysis
| Number of patients | French cohort (n = 115) | Swiss cohort (n = 88) | |
|---|---|---|---|
| Demographic characteristics | |||
| Age – median (IQR) – years | 200 | 62 (54–72) | 63 (57–74) |
| Male sex – No./total No. (%) | 201 | 82/113 (73) | 56/88 (64) |
| ICU or transfer to ICU or death – No. /total No. (%) | 200 | 61/112 (54) | 40/88 (45) |
| Outcome - No. /total No. (%) | 173 | ||
| Death | 32/107 (30) | 8/66 (12) | |
| Discharge alive | 75/107 (70) | 58/66 (88) | |
| Median interval from first symptoms on admission (IQT) | 192 | 13 (9-18) | 12 (9-17) |
| Comorbidities - No./total No. (%) | |||
| Chronic cardiac disease | 197 | 22/109 (20) | 25/88 (28) |
| Chronic pulmonary disease | 197 | 14/109 (13) | 9/88 (10) |
| Diabetes | 197 | 23/109 (21) | 26/88 (30) |
| Laboratory findings on admission – Median (IQR) | |||
| C-reactive protein (CRP) – mg/L | 34 | 122 (62–196) | |
| Lactate dehydrogenase (LDH) UI/L | 31 | 466 (337–533) | |
| Clinical characteristics on admission – Median (IQR) | |||
| Score SOFA | 41 | 4 (2–7) | |
| Score SAPS2 | 40 | 32 (27–49) |